Fuel Prices and Supply Chain Disruptions: How New Zealand’s Primary Care is Adapting

New Zealand’s primary healthcare system is currently facing a multifaceted challenge. From the soaring cost of fuel hindering patient access to global supply chain instabilities affecting medicine stocks, general practitioners (GPs) are navigating a complex environment to ensure patient care remains consistent. These pressures are compounded by a shifting landscape in specialist diagnostics, particularly regarding neurodiversity.

The Impact of Rising Fuel Costs on Patient Access

Soaring fuel prices are creating a significant barrier for patients attempting to access essential healthcare. While GPs generally maintain the ability to commute to their clinics, the financial burden falls heavily on the patients.

Jo Scott-Jones, a rural GP in Ōpōtiki and Tokoroa and clinical director for the Pinnacle Midlands Health Network, has observed that some rural patients are becoming reluctant to make the trip for GP or specialist appointments at hospitals. While patients often try to prioritize these visits, the cost of travel is a tangible deterrent.

The Shift Toward Telehealth

To combat these accessibility issues, there is a growing push for expanded virtual care. Because virtual consultations became commonplace during the Covid-19 pandemic, health leaders are advocating for hospitals to increase virtual outreach into the community.

While certain conditions require in-person examinations, many services can be transitioned to telehealth, including:

• Routine follow-up appointments.
• Post-operative follow-ups.
• General consultations that do not require physical diagnostics.

Global Supply Chain Disruptions and Medicine Shortages

Beyond travel costs, the New Zealand healthcare system is grappling with medication shortages driven by international instability. The war in Iran is currently affecting supply chains worldwide, contributing to a volatile environment for pharmaceutical availability.

Luke Bradford from the Royal NZ College of GPs describes these shortages as “the biggest nuisance,” noting that doctors often receive remarkably little notice when a medication becomes unavailable. This forces clinicians to prescribe alternative medications whenever possible to ensure continuity of care.

The scale of the crisis is evident globally; reports indicate that the UK has been “weeks away” from significant medication shortages. In response to these risks, Pharmac has stated it is closely monitoring supply risks associated with the ongoing crisis.

Expanding Adult ADHD Diagnostics

In a move to reduce massive wait times and increase access to care, a significant change in prescribing and diagnostic rights has been implemented. Starting February 1, GPs and nurse prescribers are permitted to diagnose attention deficit hyperactivity disorder (ADHD) in adults.

Challenges in Implementation

Despite the expanded authority, the transition is not without obstacles. Key concerns include:

• Funding Gaps: While GPs and nurse prescribers can now diagnose ADHD, they are not funded for this service.
• Capacity Issues: Industry experts warn that scaling up services to handle the backlog of demand will take time and cannot be solved by a simple 15-minute appointment.
• Historical Barriers: Since 1999, the authority to prescribe stimulants was limited to paediatricians and psychiatrists due to abuse concerns. This lack of public capacity frequently forced adult patients to seek expensive private assessments.

The impact of delayed diagnosis is profound. Tauranga entrepreneur Freddie Bennett, who was not diagnosed until his mid-30s, shared that he struggled with mental health issues, depression and addiction before finding answers through a diagnosis. His experience highlights the necessity of increasing diagnostic capacity within the public health system.

Key Takeaways

• Fuel Costs: Rising petrol prices are leading to missed appointments, particularly for rural patients.
• Supply Chain: Global instability, including the war in Iran, is causing medication shortages that require GPs to find alternatives.
• ADHD Access: GPs and nurse prescribers can now diagnose adult ADHD as of February 1, though a lack of funding remains a hurdle.
• Digital Health: Telehealth is being positioned as a critical tool to maintain patient follow-ups amidst travel barriers.

Frequently Asked Questions

Why are medicine stocks running low in New Zealand?

Shortages are largely attributed to global supply chain disruptions caused by the war in Iran, which has impacted the availability of medications worldwide.

Can my GP now diagnose adult ADHD?

Yes, as of February 1, GPs and nurse prescribers have the authority to diagnose ADHD in adults to support reduce wait times. However, be aware that these services may not be funded.

How is the health system addressing the cost of travel for patients?

There is a strong recommendation to increase the use of telehealth for follow-up and post-operative appointments to reduce the need for patients to travel long distances.

Looking Forward

The resilience of New Zealand’s primary care depends on the ability to adapt to economic volatility and global disruptions. By integrating telehealth more deeply into hospital outreach and resolving funding gaps for neurodiversity diagnostics, the healthcare system can better support vulnerable populations and reduce the burden on both patients and providers.